Streetbeat News

Products Services

AMZN

ASUR

Asure Software (NASDAQ:ASUR) has partnered with Amazon Web Services (AWS) to join its Application Modernization Lab. The collaboration will allow Asure to leverage advancements in cloud optimization and artificial intelligence for its Human Capital Management (HCM) software solutions. The partnership aims to enhance performance, scalability, and security of Asure's offerings, and accelerate its modernization efforts.

Portfolio Pulse from Happy Mohamed

July 11, 2023 | 12:30 pm

CRM

Salesforce Inc has announced that it will be increasing list prices by an average of 9% across Sales Cloud, Service Cloud, Marketing Cloud, Industries and Tableau in August.

Portfolio Pulse from Benzinga Newsdesk

July 11, 2023 | 12:28 pm

DXR

Daxor Corporation (DXR) has announced further acquisitions and increased utilization of its BVA-100 blood volume diagnostic in the U.S. The company has expanded its blood volume analysis into five of six hospitals in the Southeast and increased utilization for clinical use at two sites. The recent launch of Daxor's ezBVA Lab service is expected to contribute significantly to the growth of BVA sales. A six-facility hospital system in Northern Kentucky and Southeastern Indiana has begun utilizing Daxor's ezBVA Lab service. Two additional hospitals have expanded the use of BVA testing.

Portfolio Pulse from Happy Mohamed

July 11, 2023 | 12:26 pm

VRDN

Viridian Therapeutics Inc (NASDAQ:VRDN) shares are falling after the company released preliminary data from its ongoing Phase 1/2 trial of VRDN-001 for chronic thyroid eye disease (TED). The data showed clinically meaningful and rapid improvement in signs and symptoms of chronic TED at week 6 after receiving two infusions of VRDN-001. However, none of the patients treated with VRDN-001 achieved complete resolution of diplopia at week 6, which could be causing investor concern. The company also provided updates on its THRIVE Phase 3 trial and subcutaneous (SC) program candidates in TED.

Portfolio Pulse from Vandana Singh

July 11, 2023 | 12:24 pm

WKSP

Worksport Ltd. (NASDAQ:WKSP) announces the initiation of final training and validation processes for their new U.S. manufacturing line of hard-folding tonneau covers. Production is expected to start in the upcoming weeks. The company has also onboarded skilled personnel and is transitioning from preparation to production phase at its manufacturing facility in West Seneca, New York. The company aims to boost revenue growth and enhance shareholder value.

Portfolio Pulse from Happy Mohamed

July 11, 2023 | 12:24 pm

ACLS

Axcelis Technologies, Inc. (NASDAQ:ACLS) has announced multiple shipments of the Purion Power Series ion implanter systems to leading silicon carbide (SiC) power device chipmakers worldwide. The shipments, all delivered in the second quarter, included a Purion H200 SiC evaluation system for a leading SiC power device manufacturer in the United States and multiple revenue systems for customers in Asia. The systems will be used in high volume production of power devices supporting automotive industry electric vehicle (EV) applications.

Portfolio Pulse from Happy Mohamed

July 11, 2023 | 12:20 pm

GMDA

Gamida Cell Ltd. (NASDAQ:GMDA) has published a sub-study of the Phase 3 clinical trial for Omisirge, its allogeneic stem cell transplant therapy. The study found that Omisirge facilitates faster immune reconstitution and a decreased rate of post-transplant viral infection compared to umbilical cord blood. Omisirge recipients demonstrated a significant advantage in median cell counts and received a higher median dose of CD34+ stem cells. The rate of infections in the first year were significantly lower with Omisirge.

Portfolio Pulse from Happy Mohamed

July 11, 2023 | 12:19 pm

PPBT

Purple Biotech Ltd. (NASDAQ/TASE: PPBT) has announced the completion of its Phase 1 dose escalation study of CM24, a first-in-class anti-CEACAM1 monoclonal antibody addressing multiple tumor types. The study involved 11 pancreatic ductal adenocarcinoma (PDAC) patients and the results showed that the investigational immunotherapy combination was well tolerated across all dose levels with no recorded Drug Limiting Toxicities. The company is now conducting a Phase 2 randomized study of CM24 in collaboration with Bristol Myers Squibb.

Portfolio Pulse from Happy Mohamed

July 11, 2023 | 12:16 pm

EBAY

eBay has acquired Certilogo, a company specializing in 'Secure by Design' digital ID technology and authentication. The terms of the deal were not disclosed. This acquisition will bring new technology to eBay's fashion category, expanding opportunities in the circular economy.

Portfolio Pulse from Benzinga Newsdesk

July 11, 2023 | 12:16 pm

PLUR

Pluri Inc. (NASDAQ:PLUR) has signed a $4.2 million contract with the U.S. National Institute of Allergy and Infectious Diseases to advance the development of its PLX-R18 cell therapy for Hematopoietic Acute Radiation Syndrome (H-ARS). The contract supports Pluri's goal to achieve marketing approval for PLX-R18 with the U.S. Food and Drug Administration (FDA). PLUR shares are trading higher by 7.6% in the premarket session.

Portfolio Pulse from Nabaparna Bhattacharya

July 11, 2023 | 12:13 pm